Take part in new BUR-EB project to improve EB care in Europe
NEWS
- Feb 28
Debra Brasil 2023 Congress
- Dec 21, 2023
Last call to get patients involved in the GRIDD study
- Dec 20, 2023
DEBRA UK's grant call for 2024
- Aug 22, 2023
Building smiles and empowering Butterfly Children- research and webinar on oral health and QoL
- Aug 22, 2023
DEBRA Spain's work in funding research, international collaboration, and EB healthcare
- Aug 14, 2023
DEBRA UK announces its first approved drug repurposing clinical trial
- Jul 14, 2023
LifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for EB
- May 3, 2023
DEBRA Chile holds 2nd Research Day for EB patients and families
- May 1, 2023
New clinical trials online tool goes live
- Mar 10, 2023
DEBRA Ireland launches an EB Expert Panel to help shape its support and research priorities
- Feb 24, 2023
DEBRA UK commissions EB patient insight study
- Feb 21, 2023
Congratulations to Amryt Pharma - recipients of a EURORDIS Black Pearl Award!
- Jan 6, 2023
Remembering Prof Jouni Uitto
- Oct 19, 2022
Epidemiology, pathological, and genetic characteristics of EB in New Zealand
- Oct 19, 2022
International EB research: selection of high-quality research proposals 2022 has started
- May 7, 2021
Take part in an international research study on burden and resources in EB - online survey
Am Heumarkt 27/1 | 1030 Vienna | Austria
DEBRA International is a charitable Association registered in Austria (ZVR 932762489)
© 2023 DEBRA International. All rights reserved. Disclaimer: any and all medical information provided by DEBRA International on this website is for informational purposes only. Information is not intended to substitute the care and guidance given by a qualified physician or other allied healthcare professional. Always seek the advice of your physician prior to starting any medications or treatment regimens. DEBRA International does not endorse any drugs, tests, or treatments that we may report.